Science -- Cohen 288 (5474): 2156

Major International AIDS Research Collaborations

Jon Cohen

BENIN

ITM; NAP Transmission

BOTSWANA
Gaborone Harvard University; McGill University; MoH Antiretroviral resistance Bristol-Myers Squibb, 2000 ($1.2 million)
Gaborone and various villages Harvard University; MoH MTCT, vaccine design, viral subtypes, VTN^† NIH, 1997 ($500,000)

BURKINA FASO
Bobo-Dioulasso Centre Muraz: Organization for Coordination and Cooperation Against Endemic Diseases, ANRS MTCT, sex workers, genetic diversity, disease progression ANRS, 1995 ($200,000)

CAMEROON
Yaoundé IRD, ITM, Cameroon CDC, University of Yaoundé Subtypes, treatment, transmission, variability EC
Yaoundé ITM, University Hospital Transmission EC, ANRS
Yaoundé New York University, University of Yaoundé Immunology, subtypes NIH ($327,000)
Countrywide Hôpital Bichat, Pasteur Institute, Aaron Diamond AIDS Research Center SIVs and new HIVs NIH, ANRS ($668,000^*)

CÔTE D'IVOIRE
Abidjan Projet RETRO-CI: U.S. CDC, MoH Epidemiology, MTCT, opportunistic infections, STDs, sex workers CDC, 1988 ($4 million)
Abidjan ANRS, French Cooperation, INSERM (French biomedical research agency), Treichville University, NAP Epidemiology, MTCT, opportunistic infections, STDs ANRS, 1994 ($1.3 million)
Abidjan Imperial College London, ITM, NAP Microbicides EC, 1988

DEMOCRATIC REPUBLIC OF CONGO
Kinshasa Johns Hopkins University, Zaire University Immunology NIH

ETHIOPIA
Addis Ababa ENARP: Ethio-Netherlands AIDS Research Project; University of Amsterdam, Netherlands Red Cross Natural history, epidemiology, viral subtypes Netherlands Ministry for Development and Cooperation, 1994 ($2 million)

GABON
Franceville International Center for Medical Research, Hôpital Bichat, Pasteur Institute, Aaron Diamond AIDS Research Center Primate SIVs and HIVs NIH, ANRS ($668,000^*)

GAMBIA
Fajara U.K. MRC, Oxford, University College London HIV-2, KS, sex workers U.K. MRC ($900,000)

KENYA
Nairobi and Mombasa University of Nairobi, University of Manitoba, University of Washington, University of Ghent, Oxford University, and others STDs, MTCT, sex workers, vaccines, immunology, epidemiology, HEPS, microbicides Canada MRC, NIH, U.K. MRC, IAVI, U.S. Agency for International Development, Canadian International Development Agency, EC; 1980 ($3.6 million)
Nairobi ITM, University of Nairobi, MoH Transmission EC

MALAWI
Blantyre Johns Hopkins University, Malawi College of Medicine HIVNET, MTCT, vitamin A NIH, 1988 ($1.4 million^*)
Lilongwe University of North Carolina, Lilongwe Central Hospital HIVNET, human herpesvirus-8, KS, MTCT, microbicides NIH ($1.4 million^*)

RWANDA
Kigali University of Alabama, National Reference Lab Long-term survivors Luxembourg, Belgian agencies; 1997 ($660,000)
Kigali Johns Hopkins Vitamin A NIH ($668,000)

SENEGAL
Dakar IRD, University of Dakar, Hôpital Bichat Subtypes ANRS, 1994 ($530,000)
Dakar Harvard University, University Cheikh Anta Diop HIV-2 NIH ($700,000)
Dakar University of Washington, University of Dakar Epidemiology, cervical cancer NIH ($453,000)

SOUTH AFRICA
Hlabisa MRC Vaccines, STDs IAVI, 1993
Mtubatuba MRC, University of Natal, University of Durban Migrants Wellcome Trust, 1995
Durban MRC, HIVNET Sex workers, epidemiology NIH, 1990
Durban MRC, Columbia University VTN^† NIH, 2000
Cape Town University of Cape Town, University of Stellenbosch Virology, epidemiology, vaccines, TB MRC, IAVI
Soweto Chris Hani Baragwanath Hospital MTCT, microbicides, prevention, pediatrics, HIVNET NIH
Various sites Population Council Microbicides NIH ($602,000)
Various sites Columbia University, University of Natal Immunity, pediatrics NIH ($387,000)

TANZANIA
Dar es Salaam, Kagera Swedish Institute for Infectious Disease Control, University of Umeå, Muhimbili University Epidemiology, immunology, natural history, behavior, MTCT, TB, vaccines SAREC, 1986 ($660,000)
Mbeya University of Munich, MoH, Muhimbili University, and others Superinfection EC, Henry Jackson Foundation, DFG (German Research Agency), Swiss Air; 2000 ($330,000)
Dar es Salaam Harvard University, Muhumbili University MTCT, subtypes, vitamins NIH ($773,000)

UGANDA
Kampala Makerere University, Johns Hopkins University, Mulago Hospital MTCT, STDs, education, HIVNET, vitamin A, vaccines NIH, 1989 ($10.7 million^*)
Kampala Case Western Reserve University, Makerere University HIVNET, pathogenesis, TB NIH, 1986 ($10.7 million^*)
Kampala Imperial College London, ITM, Uganda Virus Research Institute EC, 1998
Entebbe U.K. MRC, Uganda Virus Research Institute Natural history, immunology, subtypes, epidemiology, STDs U.K. MRC ($2.7 million)
Gulu University of Milan, Lacor Hospital Natural history, immunology, vaccines
Rakai Makerere University, Columbia University, Uganda Virus Research Institute, Johns Hopkins University, U.S. NIAID NIH ($613,000)

ZAMBIA
Lusaka University of Alabama, Zambia UAB HIV Research Project, University Teaching Hospital Discordant couples, TB, transmission, natural history, acute infection NIH, 1994 ($1.6 million)
Lusaka ITM, Tropical Disease Research Center Transmission EC
Lusaka London School of Hygiene and Tropical Medicine, MoH, University Teaching Hospital TB
ZIMBABWE
Harare U.C. San Francisco, University of Zimbabwe, Stanford HIVNET, STDs, microbicides, MTCT, immunology NIH ($437,000)

Key: Blue: Participating institutions Red: Research focus Green: Funding agencies, start date (annual budget) Map colors indicate prevalence rates (p. 2150) ANRS: National Agency for AIDS Research (France); CDC: Center for Disease Control (for given country); EC: European Commission; HEPS: Highly exposed, persistently seronegative people; HIVNET: NIH's HIV Network for Prevention Trials; IAVI: International AIDS Vaccine Initiative; IRD: Institute of Research for Development (France); ITM: Institute of Tropical Medicine, Antwerp; KS: Kaposi's sarcoma; MoH: Ministry of Health (for given country); MRC: Medical Research Council (for given country); MTCT: mother-to-child transmission; NAP: National AIDS Program (for given country); NIH: National Institutes of Health (U.S.); SAREC: Swedish International Development Cooperation Agency; STDs: sexually transmitted diseases; VTN: NIH's Vaccine Trials Network ^* Shared funding ^† Preliminary For updates see www.sciencemag.org/feature/data/africacollaborations.shl. Please send changes and additions to [email protected]